Skip to Main Content
S. Karger AG Open Menu
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 38, Issue 6
1992
Chemotherapy Cover Image for Volume 38, Issue 6
All Issues
ISSN 0009-3157
EISSN 1421-9794

Journal Name Change

Vol. 1-12 (1960-1967) were published under the journal's former title Chemotherapia.

Chemotherapy 1992, Vol. 38, No. 6

Pharmacology

Effect of Probenecid on the Pharmacokinetics of DQ-2556, a New 3-Quaternary Ammonium Cephalosporin Antibiotic, in Humans
Subject Area: Further Areas , Oncology , Pharmacology
Kohya Shiba; Masaki Yoshida; Jingoro Shimada; Atsushi Saito; Kyuichi Matsubayashi; Shinjiro Hashimoto; Kumi Yoshida; Yasuaki Osadd; Osamu Sakai
Chemotherapy (1992) 38 (6): 369–375. https://doi.org/10.1159/000239029
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Microbiology

In vitro Evaluation of BAY Y3118, a New Full-Spectrum Fluoroquinolone
Subject Area: Further Areas , Oncology , Pharmacology
K.D. Bremm; U. Petersen; K.G. Metzger; R. Endermann
Chemotherapy (1992) 38 (6): 376–387. https://doi.org/10.1159/000239031
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Antimicrobial Activity of Subinhibitory Concentrations of Ciprofloxacin against Pseudomonas aeruginosa as Determined by the Killing Curve Method and the Postantibiotic Effect
Subject Area: Further Areas , Oncology , Pharmacology
George G. Zhanel; Joanne Crampton; Sung Kim; Lindsay E. Nicolle; Ross J. Davidson; Daryl J. Hoban
Chemotherapy (1992) 38 (6): 388–394. https://doi.org/10.1159/000239032
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Antibacterial Activity of Citreamicin-Alpha (LL-E 19085 Alpha) against Gram-Positive Cocci
Subject Area: Further Areas , Oncology , Pharmacology
Hussain Qadri; Hishama Saldin; Yoshio Ueno; Saleh R. Al-Ballaa
Chemotherapy (1992) 38 (6): 395–398. https://doi.org/10.1159/000239033
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Escherichia coli Resistant to Ampicillin/Sulbactam
Subject Area: Further Areas , Oncology , Pharmacology
Robert H.K. Eng; Kenneth Yen; Sharon M. Smith; Diane M. Citron; Ellie J.C. Goldstein; Richard Greenberg; Charles E. Cherubin
Chemotherapy (1992) 38 (6): 399–404. https://doi.org/10.1159/000239034
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Exposure Effects of Netilmicin on Enterobacter cloacae Clinical Isolates
Subject Area: Further Areas , Oncology , Pharmacology
L.S. Tzouvelekis; A.F. Mentis; E. Tzelepi; A. Tsakris; K. Kyriakis; N.J. Legakis
Chemotherapy (1992) 38 (6): 405–409. https://doi.org/10.1159/000239035
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Experimental Chemotherapy

Chlorpromazine: A Drug Potentially Useful for Treating Mycobacterial Infections
Subject Area: Further Areas , Oncology , Pharmacology
Alfred J. Crowle; George S. Douvas; Mary H. May
Chemotherapy (1992) 38 (6): 410–419. https://doi.org/10.1159/000239036
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Randomized Comparison of Ceftriaxone versus Cefriaxone plus Amikacin for the Empirical Treatment of Infections in Patients with Altered Host Defense: Microbiological and Clinical Evaluation
Subject Area: Further Areas , Oncology , Pharmacology
D. D’;Antonio; G. Fioritoni; A. Iacone; M. Dell’;Isola; D. Natale; L. D’;Arcangelo; S. Betti; A. Spadano; A. Recchia; C. Mastrangelo; R. Di Gianfilippo; A. Piergallini; P. Accorsi; A. Quaglietta; G. Torlontano
Chemotherapy (1992) 38 (6): 420–427. https://doi.org/10.1159/000239037
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Inhibition of Haemophilus influenzae Adherence to Buccal Epithelial Cells by Cef uroxime
Subject Area: Further Areas , Oncology , Pharmacology
C. Jallat; A. Darfeuille-Michaud; C. Forestier; B. Joly; R. Cluzel
Chemotherapy (1992) 38 (6): 428–432. https://doi.org/10.1159/000239038
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Uptake of Flurithromycin by Human Polymorphonuclear Phagocytes: Partial Characterization of the Entry Mechanism
Subject Area: Further Areas , Oncology , Pharmacology
A. Fietta; P. Boeri; M.L. Colombo; C. Merlini; Gialdroni Grassi
Chemotherapy (1992) 38 (6): 433–440. https://doi.org/10.1159/000239039
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Activity Assays of Thiadiazine Derivatives on Trichomonas vaginalis and Amastigote Forms of Trypanosoma cruzi
Subject Area: Further Areas , Oncology , Pharmacology
J. Atienza; Martínez Díaz; Gómez Barrio; J.A. Escario; A. Herrero; C. Ochoa; J. Rodríguez
Chemotherapy (1992) 38 (6): 441–446. https://doi.org/10.1159/000239040
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Further Section

Author Index
Subject Area: Further Areas , Oncology , Pharmacology
Chemotherapy (1992) 38 (6): 447–448. https://doi.org/10.1159/000239041
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Subject Index
Subject Area: Further Areas , Oncology , Pharmacology
Chemotherapy (1992) 38 (6): 449–450. https://doi.org/10.1159/000239042
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Contents, Vol. 38, 1992
Subject Area: Further Areas , Oncology , Pharmacology
Chemotherapy (1992) 38 (6): I–VI. https://doi.org/10.1159/000239028
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Carnitine levels decrease during oxaliplatin infusion; a pilot study
Aerobic Exercise Alleviates Doxorubicin-Induced Cardiotoxicity via Inhibition of Ferroptosis
Cryoablation Combined with Programmed Cell Death Protein 1 Inhibitor Pembrolizumab for Advanced Non-Small Cell Lung Cancer
The Impacts of Active and Inactive Ghrelin on Cachexia and Immune Checkpoint Inhibitor Monotherapy in Patients with Non-Small Cell Lung Cancer
  • Online ISSN 1421-9794
  • Print ISSN 0009-3157
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal